Cardiotoxicity of the Anticancer Therapeutic Agent Bortezomib-Reference-Cited by-同舟云学术

Cardiotoxicity of the Anticancer Therapeutic Agent Bortezomib

Published:2010-06 Issue:6 Volume:176 Page:2658-2668
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Nowis Dominika,Mączewski Michał,Mackiewicz Urszula,Kujawa Marek,Ratajska Anna,Wieckowski Mariusz R.,Wilczyński Grzegorz M.,Malinowska Monika,Bil Jacek,Salwa Paweł,Bugajski Marek,Wójcik Cezary,Siński Maciej,Abramczyk Piotr,Winiarska Magdalena,Dąbrowska-Iwanicka Anna,Duszyński Jerzy,Jakóbisiak Marek,Golab Jakub

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference42 articles.

1. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

2. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate;Kerkela;Nat Med,2006

3. Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma;Mego;Ann Oncol,2007

4. Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma;Schmidinger;J Clin Oncol,2008

5. A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies;Aghajanian;Clin Cancer Res,2002

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment;Drug Design, Development and Therapy;2024-09

2. Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults;JACC: CardioOncology;2024-08

3. Severe Heart Failure after Using Bortezomib in a Patient with Multiple Myeloma and Cardiac Amyloidosis of Normal Wall Thickness;ACTA CARDIOL SIN;2024

4. Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association;Circulation;2024-04-16

5. Novel insights into cardiovascular toxicity of cancer targeted and immune therapies: Beyond ischemia with non-obstructive coronary arteries (INOCA);American Heart Journal Plus: Cardiology Research and Practice;2024-04